Lisa P. Rumin
Subscribe to Lisa P. Rumin's PostsLisa P. Rumin focuses her practice on antitrust, regulatory and litigation matters. She assists clients across a variety of industries and has represented numerous clients in the healthcare, pharmaceutical, and biotechnology industries. Lisa advises clients on mergers and acquisitions, including obtaining clearance from the Federal Trade Commission (FTC) and Department of Justice (DOJ), as well as counsels clients on issues regarding antitrust compliance, pricing, and distribution. Read Lisa Rumin's full bio here.
Blocked JetBlue-Spirit Deal Illustrates New Antitrust Approach
By Lisa P. Rumin and Anthony S. Ferrara on Apr 15, 2024
Posted In DOJ Developments, FTC Developments, Mergers & Acquisitions
As reflected in the December 2023 merger guidelines, the Federal Trade Commission and the US Department of Justice have changed the way they think about out-of-market effects, i.e., competitive effects that arise outside the relevant market. In this Law360 article, Lisa Rumin and Anthony Ferrara unpack this new approach, which was prominently demonstrated during the...
Continue Reading
Heard at the 2024 Antitrust Law Section Spring Meeting: Part II
By Lisa P. Rumin, Anthony S. Ferrara, Reese Poncia, Noah Feldman Greene, Zachary Sproull, Han Cui, Graham Hyman, Glenna Siegel, Alex Grayson, Betty Zhang and Gregory E. Heltzer on Apr 12, 2024
Posted In Agriculture, DOJ Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions, Monopolization/Abuse of Dominance
The American Bar Association Antitrust Law Section’s annual Spring Meeting concluded on April 12. The annual Spring Meeting featured updates from federal, state and international antitrust enforcers and extensive discussion on priority antitrust issues affecting various industries. In this article, we highlight takeaways from the final two days of the Spring Meeting. Read more here.
Continue Reading
Heard at the 2024 Antitrust Law Section Spring Meeting: Part I
By Gregory E. Heltzer, Lisa P. Rumin, Reese Poncia, Anthony S. Ferrara, Claire Danberg, Glenna Siegel, Bailey K. Sanders, Betty Zhang and Alex Grayson on Apr 11, 2024
Posted In DOJ Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions, Monopolization/Abuse of Dominance
The American Bar Association Antitrust Law Section’s annual Spring Meeting is underway in Washington, DC. The annual Spring Meeting features updates from federal, state and international antitrust enforcers and extensive discussion on priority antitrust issues affecting various industries. In this article, we highlight the key takeaways from the first portion of the Spring Meeting. Read...
Continue Reading
Google Moves to Dismiss Third Complaint Alleging Tying of Google Maps API Services
By Gregory E. Heltzer, Lisa P. Rumin and Glenna Siegel on Feb 28, 2024
Posted In DOJ Developments, Monopolization/Abuse of Dominance, Private Litigation
Continue Reading
Year in Review: Criminal Enforcement by the DOJ Antitrust Division in 2023
By Nicole Castle, Lisa P. Rumin, Paul M. Thompson and Glenna Siegel on Feb 8, 2024
Posted In Cartel Enforcement, DOJ Developments, Mergers & Acquisitions
When it comes to antitrust criminal enforcement, 2023 will be remembered as the year when the US Department of Justice’s (DOJ) Antitrust Division redefined and tested the outer boundaries of its authority. This report looks back at the key events from the DOJ’s year in criminal antitrust enforcement. Here’s a glimpse of what’s inside: Despite...
Continue Reading
Court Finds Red Cross Has Antitrust Immunity, Rejecting Broad Interpretation of the Sherman Act
By Bailey K. Sanders and Lisa P. Rumin on Feb 5, 2024
Posted In Monopolization/Abuse of Dominance
Continue Reading
FTC and DOJ: Preserve Your Chats!
By Zachary Sproull, Gregory E. Heltzer and Lisa P. Rumin on Feb 1, 2024
Posted In DOJ Developments, FTC Developments
The Federal Trade Commission (FTC) and the US Department of Justice (DOJ) are updating their standard preservation notices and instructions for responding to all manner of discovery (e.g., second requests, voluntary access letters, compulsory process, etc.). The update will alert parties to the steps that must be taken to preserve communication from popular business collaboration...
Continue Reading
Fourth Circuit Holds Per-Se Rule Does Not Apply in Bid-Rigging Case
By Lisa P. Rumin and Gregory E. Heltzer on Jan 10, 2024
Posted In Cartel Enforcement, Distribution/Franchising, DOJ Developments, Joint Ventures/Competitor Collaboration
WHAT HAPPENED A three-judge panel from the US Court of Appeals for the Fourth Circuit overturned an executive’s bid-rigging antitrust conviction, holding that the district court erred in applying the per se standard to the executive’s alleged bid-rigging conduct. The executive, Brent Brewbaker, rigged bids between his former employer, Contech, and its distributor, Pomona Pipe...
Continue Reading
Proposed Merger Guidelines Outline Fundamental Change of Approach to Merger Investigation and Enforcement
By Nicole Castle, Jon B. Dubrow, Noah Feldman Greene, Gregory E. Heltzer, Joel R. Grosberg, Raymond A. Jacobsen, Jr., Lisa P. Rumin, Ryan Tisch and Stephen Wu on Jul 25, 2023
Posted In DOJ Developments, FTC Developments, Mergers & Acquisitions
Mergers and acquisitions will continue to face strong headwinds at the Federal Trade Commission and the US Department of Justice under new proposed Merger Guidelines released on July 19, 2023. The Proposed Guidelines embody the antitrust agencies’ aggressive posture toward merger enforcement under the Biden administration. This On the Subject highlights the most significant changes...
Continue Reading
Heard at the 2023 Spring Meeting: Part 2
By Gregory E. Heltzer, Lisa P. Rumin, Reese Poncia, Joshua W. Eastby, Graham Hyman, Claire Danberg, Bailey K. Sanders, William Paige and Glenna Siegel on Apr 5, 2023
Posted In Consumer Protection/Privacy, DOJ Developments, FTC Developments, Healthcare Antitrust, Mergers & Acquisitions, Monopolization/Abuse of Dominance
The American Bar Association’s Antitrust Law Section held its annual Spring Meeting in Washington, DC, on March 29–31, 2023. The Spring Meeting sessions featured updates from federal, state, and international antitrust enforcers and thought-invoking discussions on leading antitrust issues facing the business community today. Following Part 1, this post summarizes key takeaways from the second...
Continue Reading
